YU78601A - 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže - Google Patents
1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadržeInfo
- Publication number
- YU78601A YU78601A YU78601A YUP78601A YU78601A YU 78601 A YU78601 A YU 78601A YU 78601 A YU78601 A YU 78601A YU P78601 A YUP78601 A YU P78601A YU 78601 A YU78601 A YU 78601A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compounds
- thienylbenzyl
- angiotensin
- imidazoles
- production
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- BKMHLMJNCPWYLO-UHFFFAOYSA-N 1-[(4-thiophen-2-ylphenyl)methyl]imidazole Chemical class C1=CN=CN1CC(C=C1)=CC=C1C1=CC=CS1 BKMHLMJNCPWYLO-UHFFFAOYSA-N 0.000 title abstract 2
- 108010021281 angiotensin I (1-7) Proteins 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- PVHLMTREZMEJCG-GDTLVBQBSA-N Ile(5)-angiotensin II (1-7) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 PVHLMTREZMEJCG-GDTLVBQBSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 4
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003178 Arterial thrombosis Diseases 0.000 abstract 1
- 208000006029 Cardiomegaly Diseases 0.000 abstract 1
- 208000031229 Cardiomyopathies Diseases 0.000 abstract 1
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 230000003143 atherosclerotic effect Effects 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 230000009843 endothelial lesion Effects 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Pronalazak se odnosi na nove 1-(p-tienilbenzil)-imidazole formule (I), gde R(1)-R(6), X i Y imaju značenje navedeno u opisu. Navedene komponente su potentni agonisti angiotenzin-(1-7)-receptora. Kao rezultat proizvodnje i oslobadjanja vazorelaksirajućih, antitrombnih i kardioprotektivnih materija kao što su ciklički 3',5'-gvanozin monofosfat (cGMP) i azotmonoksid (NO), koji predstavljaju dragocene lekove za tretman i profilaksu visokog krvnog pritiska, hipertrofije srca, insufcijencije srca, koronarnih oboljenja srca,kao što su angina pektoris, infarkt srca, vaskularna restenoza posle angipolastije, kardiomiopatije, jedne endotelne disfunkcije odn. endotelnih oštećenja, na primer, kao posledica arteriosklerotičnih procesa ili pri dijabetesu melitus, kao i kod arterio i venozne tromboze.$The invention relates to novel 1-(p-thienylbenzyl)-imidazoles of formula (I), wherein radicals R(1)-R(6), X and Y have the meaning cited in the description. Said compounds are potent agonists of angiotensin-(1-7) receptors. As a result of the production and release of vasodilating, antithrombotic and cardioprotective messengers such as cyclic 3',5'-guanosine monophosphate (cGMP) and nitrogen monoxide (NO) associated with the stimulation of said receptors in the endothelial cells, said compounds represent valuable medicaments in the treatment and prophylaxis of hypertension, heart hypertrophy, heart failure, coronary heart diseases such as Angina Pectoris, myocardial infarct, vascular restenosis following angioplasty, cardiomyopathy, endothelial dysfunction or endothelial lesions, e.g. as a result of atherosclerotic processes or in case of Dlabetis mellitus and arterial or venous thrombosis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999120815 DE19920815A1 (de) | 1999-05-05 | 1999-05-05 | 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE1999161686 DE19961686A1 (de) | 1999-12-21 | 1999-12-21 | 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-1(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU78601A true YU78601A (sh) | 2005-07-19 |
Family
ID=26053245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU78601A YU78601A (sh) | 1999-05-05 | 2000-04-20 | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6235766B1 (xx) |
| EP (1) | EP1185527B1 (xx) |
| JP (1) | JP2002544130A (xx) |
| KR (1) | KR20020012207A (xx) |
| CN (1) | CN1158279C (xx) |
| AR (1) | AR023837A1 (xx) |
| AT (1) | ATE300535T1 (xx) |
| AU (1) | AU775244B2 (xx) |
| BR (1) | BR0010248A (xx) |
| CA (1) | CA2373010A1 (xx) |
| CZ (1) | CZ20013907A3 (xx) |
| DE (1) | DE50010835D1 (xx) |
| EE (1) | EE200100572A (xx) |
| HK (1) | HK1045519B (xx) |
| HR (1) | HRP20010814A2 (xx) |
| HU (1) | HUP0201311A3 (xx) |
| IL (1) | IL146198A0 (xx) |
| NO (1) | NO20015309L (xx) |
| NZ (1) | NZ515242A (xx) |
| PL (1) | PL351609A1 (xx) |
| RU (1) | RU2247121C2 (xx) |
| SK (1) | SK15942001A3 (xx) |
| TR (1) | TR200103171T2 (xx) |
| WO (1) | WO2000068226A1 (xx) |
| YU (1) | YU78601A (xx) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630498B2 (en) * | 1997-08-06 | 2003-10-07 | Smithkline Beecham Corporation | Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation |
| US6329159B1 (en) * | 1999-03-11 | 2001-12-11 | Millennium Pharmaceuticals, Inc. | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function |
| DE10112041A1 (de) * | 2001-03-14 | 2002-09-26 | Aventis Pharma Gmbh | p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| CA2449150C (en) | 2001-05-31 | 2011-07-12 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin ii agonists |
| KR100938817B1 (ko) * | 2001-05-31 | 2010-01-26 | 바이코어 파마 아베 | 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물 |
| US6610726B2 (en) * | 2001-06-29 | 2003-08-26 | North Shore-Long Island Jewish Research Institute | Compositions and agents for modulating cellular proliferation and angiogenesis |
| US7413751B2 (en) * | 2001-10-25 | 2008-08-19 | Depomed, Inc. | Methods of treatment using a gastric retained losartan dosage |
| EP1485116A4 (en) * | 2002-02-27 | 2006-06-07 | Univ Wake Forest | ANGIOTENSIN- (1-7) AND AGONISTS OF ANGIOTENSIN- (1-7) FOR THE INHIBITION OF GROWTH OF CANCER CELLS |
| EP1348440A1 (en) * | 2002-03-28 | 2003-10-01 | Citeq B.V. | Use of angiotensin 1-7 for enhancing cardiac function |
| NL1021048C2 (nl) | 2002-07-11 | 2004-01-13 | Weir Netherlands B V | Zuigermembraanpomp. |
| AU2003302106A1 (en) * | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| AU2003302027A1 (en) * | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| AU2003219291A1 (en) * | 2003-03-24 | 2004-10-18 | Vicore Pharma Ab | Bicyclic compounds useful as angiotensin ii agonists |
| WO2006047289A2 (en) * | 2004-10-21 | 2006-05-04 | Medtronic, Inc. | Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function |
| US8080571B2 (en) * | 2005-04-12 | 2011-12-20 | Vicore Pharma Ab | Tricyclic angiotensin II agonists |
| BRPI0502497A (pt) * | 2005-06-28 | 2007-02-06 | Univ Minas Gerais | uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças |
| BRPI0602366B1 (pt) * | 2006-04-26 | 2017-12-12 | Universidade Federal De Minas Gerais | Use of agonists of the receptor coupled to protein g, but, in the treatment of metabolic syndrome, its components and their complications |
| US20100055147A1 (en) * | 2006-10-27 | 2010-03-04 | Edze Jan Tijsma | Angiotensin (1-7) eluting stent |
| KR100885197B1 (ko) * | 2008-09-25 | 2009-02-24 | 박창수 | 다면다각형상 구현이 용이한 엘이디조명 램프용 인쇄회로기판 |
| ES2393455T3 (es) | 2008-09-12 | 2012-12-21 | Charité-Universitátsmedizin Berlin (Charité) | Uso de un agonista del receptor Ang-(1-7) en lesiones pulmonares agudas |
| US20150057216A1 (en) * | 2011-12-16 | 2015-02-26 | Tarix Pharmaceuticals Ltd. | Angiotensins for treatment of fibrosis |
| EP2819687A4 (en) * | 2012-02-10 | 2015-09-30 | Tarix Pharmaceuticals Ltd | COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE |
| US8557958B1 (en) * | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| US8633158B1 (en) | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| WO2014189634A1 (en) * | 2013-04-19 | 2014-11-27 | University Of Iowa Research Foundation | Angiotensins in muscular dystrophy |
| JP2016520592A (ja) | 2013-05-24 | 2016-07-14 | タリックス ファーマシューティカルズ リミテッド | マルファン症候群および関連障害の処置におけるアンジオテンシンペプチド |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| KR20170026368A (ko) | 2014-07-17 | 2017-03-08 | 유니버시티 오브 써던 캘리포니아 | 근골격 질환들의 치료를 위한 방법들, 화합물들 및 조성물들 |
| US10960045B2 (en) | 2015-10-14 | 2021-03-30 | Constant Therapeutics Llc | Methods and compositions for the treatment of epidermolysis bullosa |
| WO2018005591A1 (en) | 2016-06-29 | 2018-01-04 | Universite De Montreal | Biarylmethyl heterocycles |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| GB201913603D0 (en) * | 2019-09-20 | 2019-11-06 | Vicore Pharma Ab | New compounds |
| EP4117703A1 (en) | 2020-03-13 | 2023-01-18 | Constant Therapeutics LLC | Methods and compositions for treatment of coronavirus infection |
| GB202004094D0 (en) * | 2020-03-20 | 2020-05-06 | Vicore Pharma Ab | New compounds and uses |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5140037A (en) * | 1990-03-20 | 1992-08-18 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| US5177074A (en) | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5252574A (en) | 1991-04-26 | 1993-10-12 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted thiophene or furan |
| US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5256667A (en) | 1991-09-25 | 1993-10-26 | Merck & Co., Inc. | Quinazolinones and pyridopyrimidinones |
| WO1994027597A1 (en) * | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
| US5444067A (en) | 1993-08-30 | 1995-08-22 | Merck & Co., Inc. | Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety |
| FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
-
2000
- 2000-04-20 YU YU78601A patent/YU78601A/sh unknown
- 2000-04-29 IL IL14619800A patent/IL146198A0/xx unknown
- 2000-04-29 TR TR2001/03171T patent/TR200103171T2/xx unknown
- 2000-04-29 WO PCT/EP2000/003891 patent/WO2000068226A1/de not_active Application Discontinuation
- 2000-04-29 PL PL00351609A patent/PL351609A1/xx not_active Application Discontinuation
- 2000-04-29 AT AT00929466T patent/ATE300535T1/de not_active IP Right Cessation
- 2000-04-29 CZ CZ20013907A patent/CZ20013907A3/cs unknown
- 2000-04-29 NZ NZ515242A patent/NZ515242A/en unknown
- 2000-04-29 CN CNB008067996A patent/CN1158279C/zh not_active Expired - Fee Related
- 2000-04-29 EE EEP200100572A patent/EE200100572A/xx unknown
- 2000-04-29 BR BR0010248-2A patent/BR0010248A/pt not_active IP Right Cessation
- 2000-04-29 KR KR1020017014082A patent/KR20020012207A/ko not_active Application Discontinuation
- 2000-04-29 CA CA002373010A patent/CA2373010A1/en not_active Abandoned
- 2000-04-29 AU AU47536/00A patent/AU775244B2/en not_active Ceased
- 2000-04-29 JP JP2000616200A patent/JP2002544130A/ja active Pending
- 2000-04-29 DE DE50010835T patent/DE50010835D1/de not_active Expired - Lifetime
- 2000-04-29 EP EP00929466A patent/EP1185527B1/de not_active Expired - Lifetime
- 2000-04-29 RU RU2001132724/04A patent/RU2247121C2/ru not_active IP Right Cessation
- 2000-04-29 SK SK1594-2001A patent/SK15942001A3/sk unknown
- 2000-04-29 HU HU0201311A patent/HUP0201311A3/hu unknown
- 2000-05-03 AR ARP000102117A patent/AR023837A1/es unknown
- 2000-05-04 US US09/564,544 patent/US6235766B1/en not_active Expired - Lifetime
-
2001
- 2001-03-16 US US09/809,008 patent/US6429222B2/en not_active Expired - Lifetime
- 2001-10-30 NO NO20015309A patent/NO20015309L/no not_active Application Discontinuation
- 2001-11-05 HR HR20010814A patent/HRP20010814A2/hr not_active Application Discontinuation
- 2001-12-13 US US10/013,459 patent/US20020077344A1/en not_active Abandoned
-
2002
- 2002-09-26 HK HK02107057.3A patent/HK1045519B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6235766B1 (en) | 2001-05-22 |
| HK1045519B (zh) | 2005-04-22 |
| RU2247121C2 (ru) | 2005-02-27 |
| WO2000068226A1 (de) | 2000-11-16 |
| TR200103171T2 (tr) | 2002-06-21 |
| US6429222B2 (en) | 2002-08-06 |
| CN1158279C (zh) | 2004-07-21 |
| US20010018449A1 (en) | 2001-08-30 |
| BR0010248A (pt) | 2002-02-13 |
| HUP0201311A2 (en) | 2002-10-28 |
| NO20015309D0 (no) | 2001-10-30 |
| AR023837A1 (es) | 2002-09-04 |
| PL351609A1 (en) | 2003-05-05 |
| NO20015309L (no) | 2001-12-28 |
| HRP20010814A2 (en) | 2003-02-28 |
| EP1185527B1 (de) | 2005-07-27 |
| ATE300535T1 (de) | 2005-08-15 |
| EE200100572A (et) | 2003-02-17 |
| CN1349530A (zh) | 2002-05-15 |
| SK15942001A3 (sk) | 2002-04-04 |
| DE50010835D1 (de) | 2005-09-01 |
| AU4753600A (en) | 2000-11-21 |
| CZ20013907A3 (cs) | 2002-02-13 |
| US20020077344A1 (en) | 2002-06-20 |
| HUP0201311A3 (en) | 2003-03-28 |
| HK1045519A1 (en) | 2002-11-29 |
| JP2002544130A (ja) | 2002-12-24 |
| IL146198A0 (en) | 2002-07-25 |
| EP1185527A1 (de) | 2002-03-13 |
| AU775244B2 (en) | 2004-07-22 |
| CA2373010A1 (en) | 2000-11-16 |
| KR20020012207A (ko) | 2002-02-15 |
| NZ515242A (en) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU78601A (sh) | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže | |
| MY134696A (en) | Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them | |
| PL315153A1 (en) | Morpholinic and thiomorpholinic antagonists of tachykinin | |
| Gross et al. | Transfer of synthetic sialic acid analogs to N-and O-linked glycoprotein glycans using four different mammalian sialyltransferases | |
| HUT71116A (en) | Thieno-pyrimidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| NZ330292A (en) | Imidazoquinazoline derivatives | |
| TR200103273T2 (tr) | Hemisentetik yöntem ve yeni bileşimler. | |
| BR0111230A (pt) | Composto, e, uso e processo para a preparação do mesmo | |
| KR920702371A (ko) | 기본 섬유아세포 성장 인자의 효소적 제조방법 | |
| NZ258683A (en) | Substituted dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases | |
| CA2040905A1 (en) | Carbohydrate derivatives comprising a trisaccharide unit | |
| CA2360767A1 (en) | Tricyclic benzodiazepines as vasopressin receptor antagonists | |
| CA2080705A1 (en) | Substituted pyrimidines | |
| YU84700A (sh) | Benzimidazoli, njihovo pripremanje i njihova upotreba kao lekova | |
| DE59913103D1 (de) | Substituierte 4-amino-2-aryl-cyclopenta ädüpyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| CA2232240A1 (en) | Peptide for inhibiting growth of smooth muscle cells | |
| HUP9803000A2 (hu) | Ciklopeptidszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| CA2362363A1 (en) | Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them | |
| RU95108553A (ru) | Способ получения нуклеозидных аналогов с использованием бициклических промежуточных продуктов | |
| BG100954A (en) | Derivatives of hydrosamic acid, pharmaceutical compositions based on them and method for their preparation | |
| HUT70949A (en) | Triazolopyrimidin derivatives, process for preparing them and pharmaceutical compositions of angiotensine ii receptor antagonistic activity containing the same | |
| Weber et al. | Diarylsulfonamides as selective, non-peptidic thrombin inhibitors | |
| NO982242L (no) | Heparinanaloge kopolymerer, deres fremstilling og anvendelse | |
| NO176177C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-tetrahydroisokinolinderivater | |
| MX9708021A (es) | Fenilamidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparacion. |